Plunkett Research Online: Cleveland BioLabs Inc

CLEVELAND BIOLABS INC (CBLI) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries around programmed cell death to develop treatments for cancer and protection of normal tissues from radiation and other stresses. The company’s pipeline includes products from two main familie.....


CLEVELAND BIOLABS INC

Ticker: CBLI
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 716 849-6810
Fax: 716 849-6820
Address: 73 High Street Buffalo
Buffalo, NY 14203 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Yakov Kogan CEO/CFO/Secretary
Andrei Gudkov Chief Scientific Officer
See More
Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries around programmed cell death to develop treatments for cancer and protection of normal tissues from radiation and other stresses. The company’s pipeline includes products from two main familie.....See More See More

$USD, In whole numbers 2020 2019 2018 2017 2016 2015 2014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture